Atea Pharmaceuticals
AVIR
#7576
Rank
HK$2.12 B
Marketcap
HK$25.10
Share price
2.06%
Change (1 day)
7.02%
Change (1 year)

EPS for Atea Pharmaceuticals (AVIR)

EPS in 2023 (TTM): -HK$10.03

According to Atea Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$9.96. In 2022 the company made an earnings per share (EPS) of -HK$10.90 a decrease over its 2021 EPS that were of HK$11.36.

EPS history for Atea Pharmaceuticals from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$10.03-7.96%
2022-HK$10.90-195.89%
2021HK$11.36-645.91%
2020-HK$2.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.97 70.31%๐Ÿ‡บ๐Ÿ‡ธ USA